Quantcast

Latest Biologic Stories

2015-04-20 23:03:47

Catalent’s Zydis® Technology Used to Develop Thermo Stable and Cold-Chain Independent Vaccines Somerset, NJ (PRWEB) April 20, 2015 Catalent, the

2015-04-20 08:30:45

INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the investigational medicine ixekizumab was statistically superior to placebo in the treatment

2015-04-16 08:33:17

PORTLAND, Oregon, April 16, 2015 /PRNewswire/ -- A new report by Allied Market Research, titled, "Global Intravenous Immunoglobulin (IVIG) Market - Size, Industry Analysis,

2015-04-16 08:33:00

Disability Community Calls for Consumer Safeguards and Guidance from FDA for New Category of Biologic Drugs WASHINGTON, April 16, 2015 /PRNewswire-USNewswire/ --

2015-04-16 08:31:31

BEIJING, April 16, 2015 /PRNewswire/ -- China Biologic Products, Inc.

2015-04-16 04:21:54

OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,

2015-04-15 12:30:09

CRANBURY, N.J., April 15, 2015 /PRNewswire/ -- Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing biosimilars, today announced that clinical development

2015-04-14 23:05:39

Catalent Pharma Solutions (Booth 1546), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced

2015-04-13 04:21:52

LAKE FOREST, Ill., April 13, 2015 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and


Word of the Day
cespitose
  • Growing in low tufty patches.
The word 'cespitose' comes from a Latin word meaning 'turf'.
Related